OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing drugs targeting epidemic viruses
Vigneshwaran Namasivayam, Palaniappan Senthilkumar, Murugesan Vanangamudi
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1874-1894
Closed Access | Times Cited: 6
Vigneshwaran Namasivayam, Palaniappan Senthilkumar, Murugesan Vanangamudi
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1874-1894
Closed Access | Times Cited: 6
Showing 6 citing articles:
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 37
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 37
Drug repurposing: An emerging approach to drug discovery
Hareendran G. Haritha, S. Dhanya, Xavier Prasad Daniel, et al.
i-manager s Journal on Chemical Sciences (2024) Vol. 4, Iss. 1, pp. 24-24
Closed Access | Times Cited: 1
Hareendran G. Haritha, S. Dhanya, Xavier Prasad Daniel, et al.
i-manager s Journal on Chemical Sciences (2024) Vol. 4, Iss. 1, pp. 24-24
Closed Access | Times Cited: 1
Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases
Amritha G. Nambiar, Anuj A. Biswas, Ashish Kumar Agrawal, et al.
Drug repurposing (2024), pp. 135-171
Closed Access
Amritha G. Nambiar, Anuj A. Biswas, Ashish Kumar Agrawal, et al.
Drug repurposing (2024), pp. 135-171
Closed Access
Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments
Qiantong Liu, Yan‐Yun Liu, Tingting Liu, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access
Qiantong Liu, Yan‐Yun Liu, Tingting Liu, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
Stéphane Vignot, Alban Dhanani, Isabelle Sainte‐Marie, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Stéphane Vignot, Alban Dhanani, Isabelle Sainte‐Marie, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Experimental Justification of Reprofiling of the Drug Maxar® for the Treatment of Viral Infections
Т. С. Запорожец, Krylova Nv, Sergey A. Fedoreyev, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 5-6, pp. 4-10
Open Access
Т. С. Запорожец, Krylova Nv, Sergey A. Fedoreyev, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2023) Vol. 68, Iss. 5-6, pp. 4-10
Open Access
